Get back on topic21 Jul 2020 13:58
Hemogenyx is a fantastic oppertunity and this chat is doing nothing but masking that fact.
It has a pipeline coming that will blow the competition in this space away.
In pharma you should expect years not days, so a few months for CDX is nothing, some of us thought perhaps the Licencing Agreement would be signed this week? Clearly we were wrong its not coming this week or likely in the next few weeks, fine... When that one does happen expect the SP to be £'s not P's.
The 3 month extension was never about EVERYTHING else, it does not affect work on Covid-19 Antibodies or tests, it does not limit work with ALL or Hu-PHEC or god knows what else Vlad is cooking up.
If you read the RNS's, listen to the presentations, try and join the web conferences it should be obvious that Hemogenyx is going to be big in the very near future.
YOU NEED TO READ. Hemogenyx is the equivelent of SYN, ODX and NCYT in one small cap. It has a potential test, it has a potential preventative treatment, it has a potential cure, it has an alternative to bone marrow donations, it has an alternative to chemotherapy, it has an alternaive to radiotherapy, it has a platform to quickly identify future Disease X's like Covid-19 and produce antibodies.
Pull your heads out of your behinds, stop bickering over one TINY part of a presentation which in 3 months will be completely irrelevant. 12 months down the line Hemogenyx COULD be worth BILLIONS. If you want to waste hour after hour, day after day arguing the smallest details feel free, or you could just go away, come back in a few weeks or months and see whats happened.
If you CARE that much about day to day fluctuations in the share price your in the wrong share!
Ask yourself do you believe Vlad will deliver? If the answer is yes, set an alert on RNS and go do some work.